Seeing Is Believing
Currently out of the existing stock ratings of Biren Amin, 26 are a HOLD (16.35%), 132 are a BUY (83.02%), 1 are a SELL (0.63%).
Analyst Biren Amin works with a stock forecast success ratio of 54.83% fulfilled within 240.88 days on average. Previously, Biren Amin worked at JEFFERIES.
Biren Amin’s has documented 310 price targets and ratings displayed on 34 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CCCC, C4 Therapeutics at 11-Aug-2023.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$1.5 (23.08%)
7.85
10 months 13 days ago
2/2 (100%)
$6.27 (362.43%)
358
Buy
8.15
$1.65 (25.38%)
8.15
1 years 1 months 3 days ago
2/4 (50%)
$6.3 (340.54%)
433
Buy
8
$1.5 (23.08%)
11
2 years 1 months 15 days ago
1/3 (33.33%)
$5.1 (175.86%)
768
Buy
6.87
$5.74 (507.96%)
3 years 1 months 2 days ago
0/1 (0%)
$3.72 (118.10%)
Buy
7
$4.56 (186.89%)
6 years 11 months 29 days ago
0/2 (0%)
$4.6 (103.40%)
What Year was the first public recommendation made by Biren Amin?